Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized Study Evaluating ViBone®, Demineralized Bone Matrix, and Bone Morphogenetic Protein in 3-Level Oblique Lateral Lumbar Interbody Fusion

NCT03896347 is registered in ClinicalTrials.gov with Elutia Inc. as lead sponsor.

NCT NCT03896347
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03896347 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized Study Evaluating ViBone®, Demineralized Bone Matrix, and Bone Morphogenetic Protein in 3-Level Oblique Lateral Lumbar Interbody Fusion
Lead sponsor
Elutia Inc.
Phase
Observational
Overall status
Withdrawn
Start date
July 1, 2019
Completion date
February 13, 2020
Enrollment
0 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

degenerative disc disease, retrolisthesis, spondylolisthesis